Bajaj Healthcare regulatory approval announcements

Every Bajaj Healthcare regulatory approval announcement on NSE and BSE, newest first, each with its own page.

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements

12 Aug 2026 16:41 IST NSE

Regulatory Approval Bajaj Healthcare Ltd BAJAJHCARE

Bajaj Healthcare Regulatory Approval

Bajaj Healthcare received DCGI approval to manufacture and market Cenobamate API and tablets across six strengths in India. This adds a new product to its portfolio.

Open announcement → Read the filing ↗

26 Jun 2026 18:20 IST BSE

Regulatory Approval Bajaj Healthcare Ltd BAJAJHCARE

Bajaj Healthcare Regulatory Approval

Bajaj Healthcare received SEC-CDSCO recommendation to manufacture and market Cenobamate Tablets. This regulatory milestone supports the company's growth in the specialty pharmaceuticals segment.

Open announcement → Read the filing ↗